Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics is a research paper published in Frontiers in Cardiovascular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL153599
NIDDK NIH HHS
Grant: R01 DK113775
National Institutes of Health
Grant: 1R01HL147565-01
IL-35 inhibits gut microbiota-produced uremic toxin-accelerated endothelial cell activation
National Institutes of Health
Grant: 5R01HL138749-04
The roles of miR-155 in regulating atherosclerosis and metabolically healthy obesity
National Institutes of Health
Grant: 1R01HL132399-01A1
IL-35 suppression of endothelial cell activation and atherosclerosis
Fields of Study
Keywords